AMBOSS

What AMBOSS does

AMBOSS is a digital medical knowledge platform founded in 2012 and headquartered in Berlin, with US operations through AMBOSS MD Inc. in New York. The company serves medical students, practicing clinicians, and healthcare educational institutions through a subscription product that combines a curated Knowledge Library of 20,000+ expert-reviewed medical topics with an integrated 4,100+ question Qbank covering USMLE, COMLEX, Shelf, PANCE, EOR, ANCC, and AANP exams. Specialized sub-products serve physician assistant and nurse practitioner students, while two 2024 acquisitions (NEJM Knowledge+ from NEJM Group and Novaheal) extend the platform into clinician board prep and nursing education respectively.

The platform is built on AWS and is delivered via web, native iOS and Android apps, Anki and Chrome extensions (including Quizlet integration), and a ChatGPT add-on. Its proprietary AI capability centers on LiSA 1.0, which powers AI Mode Learning (a generative AI study copilot) and AI Mode Clinical Care (point-of-care clinical decision support). LiSA 1.0 was ranked #1 among 31 AI systems in the Stanford-Harvard NOHARM Study for clinical care safety, outperforming board-certified internists by more than 15 percentage points and, in multi-agent configurations with Meta Llama 4 Scout and Google Gemini 2.5 Pro, reaching top-quartile safety performance approximately 6x more often.

AMBOSS monetizes through individual subscriptions priced $338–$448 for 3- to 12-month tiers and institutional licenses to medical schools, PA/NP programs, and residency programs (with named customers including Yale, Weill Cornell, UW Medicine, HCA Healthcare, Icahn Mount Sinai, NYU Grossman, University of Colorado, University of Maryland, UAB, and Duke), supported by a 5-day free trial and 30-day money-back guarantee. The company has raised approximately $298M in cumulative funding, with the most recent €240M round in March 2025 led by KIRKBI, M&G Investments, and Lightrock earmarked for technology investment, international expansion, and further acquisitions, and management has publicly signaled IPO preparation.

Name

AMBOSS

Legal name

AMBOSS SE

Website

https://amboss.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

501–1,000 employees

Short description

AMBOSS is a Berlin-based digital medical knowledge platform serving 1M+ students, clinicians, and institutions across 180 countries through an integrated Knowledge Library, Qbank, and AI-powered clinical decision support, monetized via individual and institutional subscriptions.

Ownership category

akta.pro rank

Product category

Medical Education Software

NAICS

Educational Support Services (611710), Custom Computer Programming Services (541511)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Healthcare & Clinical Professional Development (CME/CE) (EDAGANAJ)

akta.pro secondary industry

Nursing & Allied Health Certification Prep (CNA, EMT/Paramedic, Radiology, Sonography, PT/OT) (EDANAIAB)

Keywords

• Medical education software
• Clinical decision support
• Medical knowledge library
• Exam preparation platform
• Healthcare learning tools

Headquarters

HQ city

Berlin

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Individual Subscriptions: Subscription-based access to the AMBOSS platform including Knowledge Library, Qbank, AI features, and clinical tools. Available in 1-month, 3-month, and 12-month terms with annual billing.
2. Institutional Licensing: Campus and clinic licenses for medical schools, PA programs, NP programs, and residency programs. Provides group access with administrative dashboards and usage analytics.
3. Group Discounts: Volume-based pricing for student groups, with discounts increasing based on number of registrants.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels10 records

Core offering

AMBOSS is a digital medical knowledge platform that combines a comprehensive Knowledge Library of 20,000+ expert-reviewed medical topics with an integrated Qbank of 4,100+ exam-preparation questions, AI-powered learning and clinical decision support tools (LiSA 1.0), and specialized offerings for medical students, physician assistant students, nurse practitioner students, and practicing clinicians. The platform supports USMLE, COMLEX, PANCE, ANCC, and board certification exam preparation alongside point-of-care clinical reference, distributed via web, mobile apps, and institutional licenses.

Product overview

AMBOSS is a unified medical education and clinical decision support platform that combines a comprehensive Knowledge Library with an integrated Qbank, AI-powered learning tools, and point-of-care clinical resources. The core platform consists of the AMBOSS Knowledge Library (20,000+ medical topics) and AMBOSS Qbank (4,100+ exam questions) connected through AI Mode Learning and AI Mode Clinical Care. Specialized sub-products serve PA Students (PANCE/EOR prep) and NP Students (ANCC/AANP prep), while add-ons including Anki integration, Chrome Extension, Clinical Decision Support Tools, Score Predictor, and Clinician Mode extend functionality. The platform has been expanded through acquisitions of NEJM Knowledge+ (clinical education) and Novaheal (nursing education). Users can access resources via web, iOS/Android mobile apps, and institutional licensing for medical schools and residency programs.

Differentiator

Problem solved

Functional benefit

Brands

• AMBOSS LiSA 1.0: AMBOSS AI Mode - AI clinical care and learning system that ranked #1 in the Stanford-Harvard NOHARM Study for clinical care safety.
• NEJM Knowledge+
• Novaheal

Products and services

• AMBOSS Knowledge Library A comprehensive digital medical library containing over 20,000 expert-authored and continuously updated medical topics across articles, illustrations, and multimedia content. Serves medical students, clinicians, PA/NP students, and faculty as the foundational knowledge base of the AMBOSS platform, with every Qbank question linked to relevant Knowledge Library content for seamless study-to-practice transitions.
• AMBOSS Qbank A question database of more than 4,100 case-based vignettes for USMLE Step 2 CK, Shelf exams, COMAT, PANCE, EOR, and basic science preparation, with realistic exam interfaces, detailed answer explanations, and performance tracking linked to the Knowledge Library. Targets medical students, PA students, and residents preparing for licensing and certification exams.
• AI Mode Learning An AI study copilot that helps learners turn natural-language questions and uploaded materials (notes, slides) into trusted explanations, targeted Qbank practice sessions, Anki card recommendations, and clear next-step study guidance. Built on the AMBOSS Knowledge Library and serves medical, PA, and NP students as a personalized learning assistant.
• AI Mode Clinical Care (LiSA 1.0) An AI-powered clinical decision support tool for practicing clinicians that provides evidence-based diagnostic and treatment guidance at the point of care. Backed by the AMBOSS Knowledge Library and ranked #1 in the Stanford–Harvard NOHARM Study for clinical care safety, serving physicians, residents, attendings, and advanced practice providers.
• AMBOSS for PA Students A specialized version of the AMBOSS platform tailored for physician assistant students, featuring Qbanks for PANCE and End of Rotation exams mapped to NCCPA and PAEA blueprints, clinical survival guides, and tools supporting both didactic and clinical year PA education.
• AMBOSS for NP Students A specialized version of the AMBOSS platform for nurse practitioner students, featuring ANCC and AANP certification Qbanks mapped to clinical-grade knowledge libraries, personalized study plans, and evidence-based clinical support tools.
• NEJM Knowledge+ A medical education product acquired from NEJM Group and integrated into AMBOSS's clinical decision support platform, combining NEJM's evidence-based content with AMBOSS's AI-powered tools to enhance board exam preparation and clinical practice resources for healthcare professionals.
• Novaheal A German nursing education platform acquired by AMBOSS in October 2024, specializing in nursing student and professional learning resources. Strengthens AMBOSS's position in the nursing sector and expands its healthcare education ecosystem beyond medicine into nursing.

Quantifiable outcome

• Students who used AMBOSS as primary Qbank scored 10.4 points higher on USMLE Step 2 CK
• +3 more outcomes

Named customers11 records

Segments6 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability6 records

Feature10 records

Partnerships

Two partnerships are on record, tiered core.

• NovahealcoreStrategic or Co-development Partner · 6 October 2024AMBOSS acquired Novaheal, a German EdTech startup specializing in nursing education platforms. The acquisition strengthens AMBOSS's position in the nursing sector and expands its offerings in healthcare education, creating a comprehensive ecosystem for healthcare professionals in medicine and nursing.
• NEJM GroupcoreStrategic or Co-development Partner · 25 April 2024AMBOSS acquired NEJM Knowledge+ from NEJM Group, integrating it into its clinical decision support platform. The acquisition aims to unify board exam preparation and clinical practice tools for healthcare professionals, combining NEJM's evidence-based content with AMBOSS's AI-powered platform.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• UWorld: UWorld is the dominant USMLE/medical board Qbank provider with deep penetration among US medical students. It is AMBOSS's closest direct competitor in exam preparation, with comparable question banks and similar student-facing subscription pricing.
• UpToDate (Wolters Kluwer): UpToDate is the leading point-of-care clinical decision support reference used by hospitals and clinicians worldwide. AMBOSS's AI Mode Clinical Care and Knowledge Library directly compete for the same clinician mindshare at the point of care.
• Lecturio: Lecturio is a medical education platform offering video lectures, Qbanks, and clinical learning content for medical students and professionals. It competes with AMBOSS on integrated exam prep + clinical knowledge across similar student and institutional segments.
• Osmosis (Elsevier): Osmosis, now part of Elsevier, provides video-based medical education and clinical learning for students and professionals. It overlaps with AMOSS's Knowledge Library and AI Mode Learning, especially in pre-clerkship and foundational content.
• TrueLearn: TrueLearn provides smart banks and analytics for USMLE, COMLEX, and medical board exams, with similar Qbank + performance analytics positioning to AMBOSS. It is a direct competitor in the medical Qbank market.
• Board Vitals: Board Vitals offers Qbanks and board prep for medical, nursing, and dental specialties. It overlaps with AMBOSS's board certification prep (ABIM, ABFM, PANCE, nursing) offerings and serves a similar clinician learner segment.
• DynaMed (EBSCO): DynaMed is an evidence-based clinical decision support tool used at the point of care by clinicians. It competes with AMBOSS's Clinical Reference and AI Mode Clinical Care for clinician attention in hospital and ambulatory workflows.

Broad incumbents

• Kaplan (test prep): Kaplan is a large incumbent in standardized test preparation (USMLE, MCAT, NCLEX) and offers broader professional education beyond medicine. It is a broad competitor in the medical student test prep market where AMBOSS competes.
• AccessMedicine (McGraw Hill): AccessMedicine is McGraw Hill's medical reference platform offering textbooks, Qbank, and clinical resources through institutional licensing. It is a broad incumbent competitor to AMBOSS in medical school library subscriptions.

Emerging players

• Sketchy Medical: Sketchy uses visual storytelling for medical education (microbiology, pharmacology, pathology). It is widely used by the same medical student audience and overlaps with AMBOSS's Knowledge Library in foundational content delivery.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/ambossmed
• YouTubeyoutube.com/channel/UC8xEQrU6VhJU6pDZd-GkJWg
• Facebookfacebook.com/amboss.med
• LinkedInlinkedin.com/company/amboss-md
• Instagraminstagram.com/amboss_med
• TikToktiktok.com/@amboss_med

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries3 records

Funding overview

Funding rounds5 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about AMBOSS